Lifecore Biomedical (NASDAQ: LFCR) net income
Lifecore Biomedical reported a net loss of $38.7m for fiscal 2025; in fiscal 2024 it reported a net profit of $12.0m. Earnings per share were −$1.27.
Lifecore Biomedical's best year of the last 10 was fiscal 2018. The biggest drop was in fiscal 2019, −98.3%. It reported a loss in 6 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$38.7m | −422.3% | −30.0% | −$1.27 |
| 2024 | $12.0m | — | 9.4% | $0.40 |
| 2023 | −$99.6m | — | −96.4% | −$3.32 |
| 2022 | −$116.7m | — | −104.9% | −$3.97 |
| 2021 | −$32.3m | — | −32.0% | −$1.12 |
| 2020 | −$38.2m | −9,392.2% | −23.9% | −$1.31 |
| 2019 | $0.4m | −98.3% | 0.1% | $0.01 |
| 2018 | $24.8m | +134.5% | 4.7% | $0.90 |
| 2017 | $10.6m | — | 2.3% | $0.39 |
| 2016 | −$11.6m | — | −2.4% | −$0.43 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Lifecore Biomedical net income compared with its sector
By net income for its latest fiscal year, Lifecore Biomedical ranks 237th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Lifecore Biomedical, −30.0%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 235th | Sight Sciences | −$38.4m | −49.7% |
| 236th | Monte Rosa Therapeutics | −$38.6m | −31.2% |
| 237th | Lifecore Biomedical | −$38.7m | −30.0% |
| 238th | RxSight | −$38.9m | −29.0% |
| 239th | Spruce Biosciences | −$39.0m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Lifecore Biomedical
- How much did Lifecore Biomedical earn in fiscal 2025?
- Lifecore Biomedical reported a net loss of $38.7m for fiscal 2025. In fiscal 2024 it reported a net profit of $12.0m.
- What are the earnings per share of Lifecore Biomedical?
- They were −$1.27 in fiscal 2025, compared with $0.40 in fiscal 2024.
- What was the most profitable year for Lifecore Biomedical?
- Of its last 10 fiscal years, fiscal 2018, with $24.8m.
- Where does Lifecore Biomedical rank in its sector by net income?
- It ranks 237th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Lifecore Biomedical come from?
- From the annual report (Form 10-K) that Lifecore Biomedical files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Lifecore Biomedical files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Lifecore Biomedical: the Lifecore Biomedical page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.